References
- Audrito V, Messana VG, Deaglio S. 2020. NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation. Front Oncol. 10:358–375.
- Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A. 2010. The multifaceted therapeutic potential of benfotiamine. Pharmacol Res. 61:482–488. doi:https://doi.org/10.1016/j.phrs.2010.02.008.
- Belenky P, Bogan KL, Brenner C. 2007. NAD+ metabolism in health and disease. Trends Biochem Sci. 32:12–19. doi:https://doi.org/10.1016/j.tibs.2006.11.006.
- Bozic I, Savic D, Stevanovic I, Pekovic S, Nedeljkovic N, Lavrnja I. 2015. Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells. Front Cell Neurosci. 9:351–365. doi:https://doi.org/10.3389/fncel.2015.00351.
- Buldak RJ, Buldak L, Polaniak R, Kukla M, Birkner E, Kubina R, Kabała-Dzik A, Duława-Bułdak A, Żwirska-Korczala K. 2013. Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. Oncol Rept. 29:771–778. doi:https://doi.org/10.3892/or.2012.2175.
- Chang I, Guggenheim C, Laird-Fick H. 2015. A case of diverticular perforation in a young patient with rheumatoid arthritis on methotrexate. Case Rept Med. 2015:617268.
- Coelho M, Oliveira T, Fernandes R. 2013. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 9:191–200. doi:https://doi.org/10.5114/aoms.2013.33181.
- Cudmore J, Seftel M, Sisler J, Zarychanski R. 2014. Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur. Can Fam Phys. 60:53–56.
- Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A. 2006. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 49:744–747. doi:https://doi.org/10.1007/s00125-006-0173-z.
- Elango T, Dayalan H, Gnanaraj P, Malligarjunan H, Subramanian S. 2014. Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients. Clin Exp Med. 14:431–437. doi:https://doi.org/10.1007/s10238-013-0252-7.
- El-Taweel HM, Salah NA, Selem AK, El-Refaeey A, Abdel-Aziz A. 2018. Visfatin gene expression and oxidative stress in pregnancy induced hypertension. Egypt J Basic Appl Sci. 5:69–74.
- El-Zorkany BK, Gamal SM, El-Mofty SA. 2013. Frequency and causes of discontinuation of methotrexate in a cohort of Egyptian patients. Egypt Rheumatol. 35:53–57. doi:https://doi.org/10.1016/j.ejr.2013.01.003.
- Fasshauer M, Blüher M. 2015. Adipokines in health and disease. Trends Pharm Sci. 36:461–470. doi:https://doi.org/10.1016/j.tips.2015.04.014.
- Fox EJ, Leeder JS, Ye SQ, Becker ML. 2013. Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate. J Rheumatol. 40:741–742. doi:https://doi.org/10.3899/jrheum.120639.
- Funk RS, Singh R, Pramann L, Gigliotti N, Islam S, Heruth DP, Ye SQ, Chan MA, Leeder JS, Becker ML. 2016. Nicotinamide phosphoribosyltransferase attenuates methotrexate response in juvenile idiopathic arthritis and in vitro. Clin Transl Sci. 9:149–157. doi:https://doi.org/10.1111/cts.12399.
- Goncalves AC, Moreira EJS, Portari GV. 2019. Benfotiamine supplementation prevents oxidative stress in anterior tibialis muscle and heart. J Integr Med. 17:423–429. doi:https://doi.org/10.1016/j.joim.2019.07.001.
- Haupt E, Ledermann H, Kopcke W. 2005. Benfotiamine in the treatment of diabetic polyneuropathy–a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther. 43:71–77. doi:https://doi.org/10.5414/CPP43071.
- Li J, Shen X. 2019. Oxidative stress and adipokine levels were significantly correlated in diabetic patients with hyperglycemic crises. Diabetol Metab Syndr. 11:13–21. doi:https://doi.org/10.1186/s13098-019-0410-5.
- Lin YC, Wu HC, Liao CC, Chou YC, Pan SF, Chiu CM. 2015. Secretion of one adipokine nampt/visfatin suppresses the inflammatory stress-induced nf-kappab activity and affects nampt-dependent cell viability in Huh-7 cells. Med Inflam. 2015:392471. doi:https://doi.org/10.1155/2015/392471.
- Longo-Sorbello GS, Bertino JR. 2001. Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica. 86:121–127.
- Mahmoud AM, Hussein OE, Hozayen WG, Abd El-Twab SM. 2017. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARgamma and Nrf2: protective effect of 18 beta-glycyrrhetinic acid. Chem Biol Interact. 270:59–72. doi:https://doi.org/10.1016/j.cbi.2017.04.009.
- Marseglia L, D’Angelo G, Manti M, Aversa S, Fiamingo C, Arrigo T, Barberi I, Mamì C, Gitto E. 2016. Visfatin: new marker of oxidative stress in preterm newborns. Int J Immunopathol Pharmacol. 29:23–29. doi:https://doi.org/10.1177/0394632015607952.
- Munro B. 1971. Manual of histologic staining methods of the Armed Forces Institute of Pathology. Pathology. 3:249. doi:https://doi.org/10.1016/S0031-3025(16)39410-7.
- Murphy MP, Hartley RC. 2018. Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov. 17:865–886.
- Peker A, Yarkıcı H, Akar H. 2018. Gastrointestinal bleeding secondary to use of high-dose methotrexate: a case report. J Surg Med. 2:151–153.
- Romacho T, Sanchez-Ferrer CF, Peiro C. 2013. Visfatin/nampt: an adipokine with cardiovascular impact. Mediat Inflam. 2013:946427. doi:https://doi.org/10.1155/2013/946427.
- Saddi-Rosa P, Oliveira CS, Giuffrida FM, Reis AF. 2010. Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr. 2:21–27. doi:https://doi.org/10.1186/1758-5996-2-21.
- Savran M, Cicek E, Doguc D, Asci H, Yesilot S, Candan I, Dagdeviren B, Cankara F, Oncu M, Uğuz A. 2017. Vitamin C attenuates methotrexate-induced oxidative stress in kidney and liver of rats. Physiol Int. 104:139–149. doi:https://doi.org/10.1556/2060.104.2017.2.5.
- Schmid U, Stopper H, Heidland A, Schupp N. 2008. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes Metab Res Rev. 24:371–377. doi:https://doi.org/10.1002/dmrr.860.
- Sglunda O, Mann H, Hulejová H, Kuklová M, Pecha O, Pleštilová L, Filková M, Pavelka K, Vencovský J, Šenolt L. 2014. Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort. PLoS One. 9:e103495. doi:https://doi.org/10.1371/journal.pone.0103495.
- Shoeb M, Ramana KV. 2012. Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages. Free Rad Biol Med. 52:182–190. doi:https://doi.org/10.1016/j.freeradbiomed.2011.10.444.
- Soares PM, Lopes LO, Mota JMS, Belarmino-Filho JN, Ribeiro RA, de Souza MHL. 2011. Methotrexate-induced intestinal mucositis delays gastric emptying and gastrointestinal transit of liquids in awake rats. Arq Gastroenterol. 48:80–85. doi:https://doi.org/10.1590/S0004-28032011000100016.
- Tsukada T, Nakano T, Miyata T, Sasaki S. 2013. Life-threatening gastrointestinal mucosal necrosis during methotrexate treatment for rheumatoid arthritis. Case Rept Gastroenterol. 7:470–475. doi:https://doi.org/10.1159/000356817.
- Xu R, Yuan Z, Yang L, Li L, Li D, Lv C. 2017. Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress. Oncol Rep. 38:1767–1773. doi:https://doi.org/10.3892/or.2017.5793.